Biogen’s Medical Writing Fellowship will focus on clinical and regulatory documents needed for drug development. Over the course of 2 years, the Fellow will work with teams that include physicians, statisticians, clinical pharmacologists, and other scientists to create the documents needed to support the conduct and reporting of clinical trials, as well as the documents needed to obtain and maintain marketing authorization for therapies.
In the first year, the Fellow will develop documents at the level of an individual clinical study of a potential new drug. These documents will include the clinical study protocol, which describes how the study will be conducted, and the clinical study report, which documents data results and conclusions of the study. As part of the cross-functional team of scientists and physicians, the Fellow will learn about the purpose, structure, and components of a protocol, and the process required to develop and adapt the protocol during the course of a study.
The Fellow will also become familiar with the interpretation and reporting of the clinical data, the purpose of the clinical study report, and the importance of these data to stakeholders.
Working within cross-functional teams provides exposure to the different scientific and medical functions that contribute to drug development and how they collaborate on clinical studies. Also, developing an understanding of how the study-level documents are created will provide the Fellow with the foundation needed to understand how individual studies support the overall drug development process.
In the second year, the Fellow will work on program-level documents that are required to support all studies within a drug development program, or to support the submission of data to regulatory authorities for marketing authorizations. This will allow the Fellow to gain experience with a wider variety of documents and an understanding of their function within the broader context of drug development.
The fellow will have the opportunity to spend up to 4 months in another department within Biogen. Departments may include, but are not limited to:
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS Fluid Review application portal. Visit https://mcphs.fluidreview.com/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via PPS to schedule interviews.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portal due by December 2, 2019:
Letter of intent
Unofficial college transcript
Contact information of three references for recommendations
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
After ASHP Midyear Clinical Meeting
The three recommendations must be submitted by the three provided contacts no later than December 16th.
Top candidates will be invited for onsite interviews at the sponsoring company’s location. Final candidates will be required to go through additional screening / onboarding as required by MCPHS University.
Applicants must hold a Doctor of Pharmacy degree from an ACPE-accredited college of pharmacy at the commencement of the program.
Candidates must have excellent written/verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
The Biogen fellows will be selected on a nationally competitive basis.
All fellowships are for the duration of two years with a start date of July 1st.
Employer will assist with relocation costs.
Additional Salary Information: Additional Salary Information: Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
About MCPHS University/Biogen
Biogen helped create an industry that has touched countless lives. We were among the world's first biotechnology companies, and today we are the oldest independent biotech firm in the world.From the start, when a group of scientists and venture capitalists were united by a new vision for serving unmet medical needs, the company's personality has reflected the multifaceted name of the industry we helped co-found: biotechnology. Biology is about life, about understanding the body's inner workings, about exploring new discoveries and insights to improve lives. Technology is about practical application, about making things work, about developing new products to help people. Biogen embodies both these worldviews. Scientific curiosity and courageous innovation helps us create new and important therapies; practicality makes us successful and vital to our patients. These values extend beyond our laboratories; our aim to discover better ways of doing things infuses all our work, from manufacturing and marketing to partnerships and human resources. At the same time, the practical application of our discoveries is what drives our scientists, as we seek treatments and therapies that can help p...atients live longer and better lives. At Biogen, we are proud of our more than 30 years of contributions to the biotechnology industry and look forward to continuing to shape the future of an industry that transforms scientific discovery into advances in patient care.